Minerva Neurosciences Inc
Stock Chart, Company Information, and Scan Results
$4.37(as of Sep 8, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Minerva Neurosciences Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$4.37
Ticker SymbolNERV
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees7
CountyUSA
Market Cap$211.5M
EBIDTA-28.5M
P/E Ratio-0.88
Forward P/E Ratio11.21
Earnings per Share-34.08
Profit MarginUnknown
RSI45.59
Shares Outstanding47.7M
ATR0.35
52-Week High8.80
Volume91,540
52-Week Low1.93
Book Value-201.6M
P/B Ratio-1.72
Upper Keltner5.40
P/S RatioUnknown
Lower Keltner3.83
Debt-to-Equity Ratio-0.36
Next Earnings DateUnknown
Cash Surplus20.7M
Next Ex-Dividend DateUnknown
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Minerva Neurosciences Inc In Our Stock Scanner
As of Sep 08, 2026
Scan Name: Bull FlagScan Type: Chart Pattern Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.